Mann D 2010.
Methods | Randomized to decision aid vs usual care | |
Participants | 80 + 70 participants diagnosed with diabetes considering the use of statins to reduce coronary risk | |
Interventions | DA (in consultation): healthcare provider led discussion using developed tool (Statin Choice) on options' outcomes,outcome probabilities, guidance (step‐by‐step process for making the decision; administered by the physician in the consultation) Comparator: usual primary care visit + pamphlet |
|
Outcomes | Knowledge (postconsult and post‐DA), decisional conflict (postconsult and post‐DA), risk estimation (postconsult and post‐DA), beliefs (postconsult and post‐DA), adherence (3 and 6 months postconsult and post‐DA) | |
Notes | Primary outcome was not specified | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Participants were randomized but there is no mention of method used (p 138, Methods section) |
Allocation concealment (selection bias) | Unclear risk | Not reported |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not reported |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Unclear blinding but outcomes were not subjective to interpretation |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Baseline data was provided |
Selective reporting (reporting bias) | Unclear risk | Only reports on improvement (i.e. decisional conflict scale); does not present outcome data to fullest (no numerical data on knowledge results between groups, only describes in words) |
Other bias | Unclear risk | "We did not adjust the clustering of effects given that few participants received care by the same clinicians" (p 139, Analysis section). No mention of magnitude in change of data due to this choice |